The researchers found that for the treatment regimen estimand, the mean change from baseline in hemoglobin A1c concentration was 1.69, 1.86, and 1.94 percent with 4, 9, and 12 mg of retatrutide, respectively, versus 0.81 percent with placebo, resulting in estimated treatment differences of 0.88, 1.04, and 1.12 percent, respectively, versus placebo
Rotating injection sites prevents local irritation accumulation
Unusual odour: An unexpected smell upon opening the vial may suggest microbial growth, though odour is an unreliable indicator and should not be used as the primary means of assessment
In such cases, supplemental L-carnitinetypically 1 to 3 grams daily in divided dosescould theoretically maintain optimal mitochondrial function
Gastrointestinal side effects represent a primary concern
The New England Journal of Medicine.